Optometry News

To detect glaucoma progression, physicians need to look at all available data and imaging, according to a presentation at Real World Ophthalmology.

As Healio’s coverage of the Association for Research in Vision and Ophthalmology meeting winds down, catch up on this year’s most popular articles.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, Mark R. Barakat, MD, discusses post hoc findings on IOP in patients receiving aflibercept 8 mg for diabetic macular edema in the PHOTON trial.

Age younger than 1 year at the time of cataract surgery, aphakia, Black race and unilateral cataract appeared linked to higher risk for developing pediatric glaucoma, according to a study published in Ophthalmology Glaucoma.

Dopavision has announced positive topline results from a proof-of-concept trial of MyopiaX, a noninvasive photobiomodulation intervention designed to slow myopia progression in children.

Merck will acquire EyeBio through a subsidiary in an agreement potentially valued at $3 billion, according to a press release.

Health Canada approved the enVista Envy full visual range IOL, the first global approval for the lens, according to a press release from Bausch + Lomb.

Lubricating eye drops with a single-polymer or dual-polymer formulation and saline were all effective in reducing epithelial surface irregularity along the horizontal meridian in a study published in Optometry and Vision Science.

New data from The Vision Council’s Consumer InSights and Market inSights reports show that the optical industry continues to grow, with rising in-person purchases for eye wear and contact lenses in the first quarter of 2024.

Ophthalmologists must work with oncologists to understand and mitigate ocular surface adverse events caused by oncologic therapeutics, according to a presentation at Real World Ophthalmology.